Ansell (FRA:PD1) Tariff Resilience Score: 7/10 (As of Jul. 04, 2026)


FRA:PD1 Ansell Ltd FRA:PD1
76 GF Score
Price €71.00
GF Value €65.78
! 4 Warning Signs
View Full Analysis

What is Ansell Tariff Resilience Score?

Ansell FRA:PD1 -0.70% 76 Tariff Resilience Score is 7 as of Jul. 04, 2026. GuruFocus rates FRA:PD1 with a GF Score™ of 76/100 and a GF Value™ of €65.78. The stock has 4 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Ansell ranks better than 98.09% on this metric.

Ansell has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Ansell has Global manufacturing footprint with diverse sales markets. Historical tariff impacts have been minimal due to strong pricing power and strategic supplier relationships. Industry-specific exemptions in healthcare provide additional resilience.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Ansell might have Highly Resilient.

Ansell  (FRA:PD1) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Ansell Tariff Resilience Score Related Terms

FRA:PD1 vs ISRG, BDX, MDLN: Tariff Resilience Score Comparison

For the Medical Instruments & Supplies subindustry, Ansell's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ansell Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Ansell's Tariff Resilience Score falls into.


FRA:PD1
76GF Score
Ansell Ltd FRA:PD1
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Ansell (FRA:PD1) has a Tariff Resilience Score of 7 as of Jul. 04, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Ansell ranks #16 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is Ansell's Tariff Resilience Score too high?
Ansell's current Tariff Resilience Score is 7. Based on the distribution chart, Ansell ranks #16 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ansell has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Ansell's Tariff Resilience Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ansell ranks #16 out of 837 companies for Tariff Resilience Score. This places Ansell in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Ansell's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Ansell (FRA:PD1) has a current Tariff Resilience Score of 7. The stock's GF Value™ is €65.78, compared to a current price of €71.00 — trading 7.9% above its estimated fair value. The current Tariff Resilience Score is 7. Ansell's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Ansell (FRA:PD1), the current Tariff Resilience Score is 7 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ansell (FRA:PD1) Overvalued in 2026?

Based on GuruFocus' analysis, Ansell stock appears to be overvalued. The current stock price of €71.00 is trading 7.9% above its estimated GF Value™ of €65.78.

Key valuation signals for FRA:PD1:

  • Tariff Resilience Score: 7
  • GF Value™: €65.78 vs. price of €71.00 (7.9% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the FRA:PD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ansell Business Description

Address 678 Victoria Street, Level 3, Richmond, Melbourne, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
76GF Score

Get the complete analysis for FRA:PD1

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€71.00
Price
€65.78
GF Value